Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Impel Pharmaceuticals Inc (NQ: IMPL ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Dec 15, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Impel Pharmaceuticals Inc Impel Pharmaceuticals Announces Exploration of Strategic Alternatives October 05, 2023 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society June 15, 2023 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update May 12, 2023 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer May 10, 2023 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023 May 05, 2023 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine Medications April 26, 2023 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors April 12, 2023 H. Stewart Parker Departing from Board From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual Meeting April 11, 2023 Highlights Include Multiple Presentations Addressing Safety and Efficacy of Trudhesa From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update March 24, 2023 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023 March 17, 2023 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in March March 03, 2023 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals Announces Strategic Repriortization, Continues Focus on Maximizing Trudhesa® Commercial Opportunity February 22, 2023 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Corporate Update November 14, 2022 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals to Participate in Guggenheim 4th Annual Immunology and Neurology Day November 08, 2022 From Impel Pharmaceuticals Via GlobeNewswire Impel Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022 November 07, 2022 From Impel Pharmaceuticals Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
